Tohoku University Tohoku Medical Megabank Organization (Hozumi Motohashi)
2020.01.21

1.   Saigusa Daisuke, Motoike Ikuko N., Saito Sakae, et al. Impacts of NRF2 activation in non–small‐cell lung cancer cell lines on extracellular metabolites. Cancer science. 2020; : cas.14278. doi:10.1111/cas.14278  
2.   Kuriyama Shinichi, Metoki Hirohito, Kikuya Masahiro, et al. Cohort Profile: Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study (TMM BirThree Cohort Study): Rationale, Progress and Perspective. International Journal of Epidemiology. 2019; : . doi:10.1093/ije/dyz169  
3.   Sekine Hiroki, Okazaki Keito, Ota Nao, et al. The Mediator Subunit MED16 Transduces NRF2-Activating Signals into Antioxidant Gene Expression. Molecular and cellular biology. 2016; 36 (3): 407-20. doi:10.1128/MCB.00785-15  
4.   Koshiba Seizo, Motoike Ikuko, Kojima Kaname, et al. The structural origin of metabolic quantitative diversity. Scientific Reports. 2016; 6 (1): 31463. doi:10.1038/srep31463  
5.   de Aguiar Vallim Thomas Q., Tarling Elizabeth J., Ahn Hannah, et al. MAFG Is a Transcriptional Repressor of Bile Acid Synthesis and Metabolism. Cell Metabolism. 2015; 21 (2): 298-310. doi:10.1016/j.cmet.2015.01.007  
6.   Suzuki Mikiko, Yamazaki Hiromi, Mukai Harumi Y., et al. Disruption of the Hbs1l-Myb Locus Causes Hereditary Persistence of Fetal Hemoglobin in a Mouse Model. Molecular and Cellular Biology. 2013; 33 (8): 1687-1695. doi:10.1128/MCB.01617-12  
7.   Suzuki Takafumi, Shibata Tatsuhiro, Takaya Kai, et al. Regulatory nexus of synthesis and degradation deciphers cellular Nrf2 expression levels. Molecular and cellular biology. 2013; 33 (12): 2402-2412. doi:10.1128/MCB.00065-13